QTREX Seeks Shareholder Nod for Staggered Board, Poison Pill, and 200% Authorized Share Expansion
QTEX has more than doubled off its 52-week low of $0.283 on light trading volume (0.1× avg).
Summary
QTREX Quantum calls a shareholder meeting to vote on a staggered board, poison pill, 200% authorized share increase, and substantial equity grants to executives and directors.
Key Events · Corporate Governance and Compliance · QTEX
-
Anti-Takeover Package Proposed
To deter hostile takeovers, the board is seeking approval for a staggered board with three classes and a 70% removal threshold, a shareholder rights plan (poison pill), and an exclusive federal forum for Securities Act claims.
-
Authorized Shares to Triple
Proposal 10 would increase authorized ordinary shares from 100 million to 300 million, providing flexibility for future capital needs but also enabling dilution of up to 200 million shares.
-
CEO and Chairman RSU Grants
Proposals 5 and 7 grant 550,000 RSUs each to CEO Dagi Ben-Noon and Chairman Tal Parnes, vesting over three years. At $0.8811 per share, each grant is worth approximately $485,000; the CEO's total fully diluted stake would reach 4.89%.
-
Director Compensation Hikes
Annual fees for non-executive directors would rise to approximately $51,269 (from $46,000), and two directors would receive a combined 270,000 RSUs. The Chairman's annual fee would increase to roughly $157,749.
Analysis · QTEX · Industrial Applications And Services
Shareholders are being asked to approve a package of anti-takeover defenses — a staggered board, a poison pill, and a near-tripling of authorized shares — alongside substantial equity grants for the CEO and Chairman. While the board contends these measures safeguard long-term value during a strategic transformation, they also entrench management and dilute existing holders. The authorized share increase to 300 million shares, coupled with the rights plan, grants the board broad authority to block unsolicited bids without a shareholder vote. The CEO and Chairman each stand to receive 550,000 RSUs, worth roughly $485,000 at today's price, while non-executive directors see fee hikes and additional RSUs. These proposals will be voted on August 28, 2026.
How filings like this one have moved
In the 30 days to Sep 14, 2026, 35.8% of the 1045 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, QTEX was trading at $0.88 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $38.4M. The 52-week trading range was $0.28 to $3.85. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.